Assessing how well influenza and COVID-19 vaccines work in diverse populations in Arizona.
RFA-IP-22-004, Platform to Assess Influenza and COVID-19 Vaccine Effectiveness in Underserved Arizona Populations
This study is looking at how well the flu and COVID-19 vaccines work for different groups of people in Arizona, especially those who might not have easy access to healthcare, to see how they help protect against getting sick.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Arizona State University-Tempe Campus NIH-funded |
| Lab location | 1 site (Tempe, United States) |
| Project ID | NIH-10908241 on NIH RePORTER |
What this research studies
This research investigates the effectiveness of influenza and COVID-19 vaccines among underserved populations in Arizona, particularly focusing on diverse demographic groups. By analyzing vaccine responses in outpatient clinics, including those treating immunocompromised patients, the study aims to understand how well these vaccines protect against infections and severe disease. The research will utilize local data to compare vaccination rates and effectiveness, especially in a region that has faced significant COVID-19 challenges.
Who could benefit from this research
Good fit: Ideal candidates include individuals from diverse ethnic and socioeconomic backgrounds, particularly those who are immunocompromised or have limited access to healthcare.
Not a fit: Patients who are not part of the underserved populations in Arizona or those who have already received all recommended vaccinations may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved vaccination strategies and better health outcomes for underserved populations.
How similar studies have performed: Previous research has shown success in assessing vaccine effectiveness in diverse populations, indicating that this approach is both relevant and necessary.
Where this research is happening
Tempe, United States
- Arizona State University-Tempe Campus — Tempe, United States (Active)
Researchers
- Principal investigator: Murugan, Vel — Arizona State University-Tempe Campus
- Study coordinator: Murugan, Vel
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.